Table 1. Demographic data of individuals with anti-HCV positive serology in the cohort.
Samples were categorized according to HCV RNA status.
| HCV RNA −ve (N = 68) | HCV RNA +ve (N = 222) | Total (N = 290) | Odds ratio (95% CI) | P-value | |
|---|---|---|---|---|---|
| Sex (M:F) | 50:18 | 192:30 | 242:48 | 2.3 (1.2, 4.5) | 0.013 |
| Age (Mean ± SD) | 50.4 ± 7.7 | 50.0 ± 7.3 | 50.1 ± 7.4 | 0.9 (0.6, 1.3) | 0.687 |
| AST (%) | 8.6 (4.7, 16.0) | <0.001 | |||
| <30 U/mL | 49 (72.1%) | 51 (23.0%) | 100 (34.5%) | ||
| ≥30 U/mL | 19 (27.9%) | 171 (77.0%) | 190 (65.5%) | ||
| ALT | 7.7 (3.9, 15.1) | <0.001 | |||
| <30 U/mL | 56 (82.4%) | 84 (37.8%) | 140 (48.3%) | ||
| ≥30 U/mL | 12 (17.6%) | 138 (62.2%) | 150 (51.7%) | ||
| Liver stiffnessa (%) | 3.9 (2.1, 7.1) | <0.001 | |||
| F0-F2 | 52 (76.5%) | 101 (45.9%) | 153 (52.9%) | ||
| F3-F4 | 16 (23.5%) | 120 (54.3%)a | 136 (47.1%) |
Notes.
a
Liver stiffness (F0-F2, <9.5 kPa; F3–F4, ≥9.5 kPa) could not be determined in 1 individual.